ROBIN LEIDECKER: Open Payments
NPI 1134877038 · SALEM, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 7 payments from 7 companies in 2025. Trend: 2023 $130 · 2024 $215 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $123 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $56 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Insulet Corporation | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
Products named: ZEPBOUND, Auvelity, CAPLYTA, REXULTI, FANAPT, Omnipod.
Industry payments across KY — which companies pay providers there.
